Camp Lejeune cancer lawsuit

Newly Released CDC Study Finds Male Breast Cancer, Lung Cancer, And Many More Diseases Were Caused At Camp Lejeune

The new list adds to kidney cancer, liver cancer, non-Hodgkin lymphoma, leukemias, bladder cancer, and other diseases

Wednesday, January 31, 2024 - Tens of thousands of US Marines, civilian employees stationed at the base, and women and children at the daycare center and schools were believed to have developed cancer from using the ordinary drinking water there. CNN tells readers what we have come to know for some time. "Drinking water at Camp Lejeune was heavily contaminated with several cancer-causing industrial chemicals, including trichloroethylene or TCE, vinyl chloride, and benzene, from 1953 to 1985. Hundreds of thousands (over one million possibly) of service members in the Marines and Navy as well as civilians employed at the base were unwittingly exposed to the chemicals when they drank the water, inhaled steam in the shower and even simply washed their hands." Less than one dozen specific types of cancer were covered by the Elective Option of the Camp Lejeune Justice Act which is intended to pay large lump sums of cash to people who have been diagnosed with certain diseases. The list of presumed illnesses, kidney cancer, liver cancer, non-Hodgkin lymphoma, leukemias, bladder cancer, multiple myeloma, Parkinson's disease, kidney disease, and systemic sclerosis, however, did not include those diseases that a 2015 study found to be Camp Lejeune water-related. The study's conclusions have been slowly walked if not covered up by the Center For Disease Control (CDC) which conducted the study. Attorneys representing people who were at Camp Lejeune and suffered an illness not included in the presumed list launched a lawsuit several years ago seeking the release of the study's cancer conclusions. Time was of the essence for the study's release because claimants for benefits under the Camp Lejeune Justice Act have only until August 2024, two years since the law's enactment, to file a claim with the Navy AG.

The newly released CDC study has found several more diseases related to time spent at Camp Lejeune. About 160,000 people have filed administrative Camp Lejeune Justice Act claims and several thousand lawsuits have been filed in the Easter District of North Carolina. Those numbers could double now that more diseases have been connected to drinking, bathing in, or otherwise ingesting contaminated Camp Lejeune water. "In addition to male breast cancer, the study identified several other cancers that had not previously been shown to be connected to the contamination there. Those included all myeloid cancers, including a type of blood cancer called polycythemia vera; myelodysplastic and myeloproliferative syndromes, a group of disorders caused by blood cells that aren't formed properly or don't work right; and cancers of the esophagus, voice box, thyroid, and soft tissue; marginal B-cell lymphoma; and some types of lung cancer," CNN reports. People who have spent at least 30 days at Camp Lejeune between 1953 and 1987 and were diagnosed with any of these types of diseases, and the loved ones of those who died from these diseases should contact a Camp Lejeune water attorney for guidance in seeking lump-sum monetary compensation.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.